INTEGRA LIFESCIENCES HOLDINGS CORP (IART) — insider trading
Health Care · NASDAQ
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) has 16 reported SEC Form 4 insider transactions in our data (latest 2026-07-03).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-03 | Knight Lea Daniels | Officer (EVP & Chief Financial Officer) | Shares withheld for taxes / exercise cost | 5,226 | $18.05 | $94.3K | Form 4 |
| 2026-07-01 | DAVIS ROBERT T. JR. | Officer (EVP & President, TR&DT) | Grant / award / vesting (derivative) | 11,180 | $0.00 | $0 | Form 4 |
| 2026-07-01 | Singh Harvinder | Officer (EVP & President, SS) | Grant / award / vesting (derivative) | 5,590 | $0.00 | $0 | Form 4 |
| 2026-07-01 | Mosebrook Jeffrey | Officer (SVP, Fin & Princ Acct Officer) | Shares withheld for taxes / exercise cost | 937 | $17.89 | $16.8K | Form 4 |
| 2026-06-01 | ESSIG STUART | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 365,297 | $0.00 | $0 | Form 4 |
| 2026-06-01 | ESSIG STUART | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 705,468 | $0.00 | $0 | Form 4 |
| 2026-06-01 | McBreen Michael J. | Officer (EVP & Chief Commercial Officer) | Grant / award / vesting (derivative) | 31,909 | $0.00 | $0 | Form 4 |
| 2026-06-01 | McBreen Michael J. | Officer (EVP & Chief Commercial Officer) | Grant / award / vesting (derivative) | 60,372 | $0.00 | $0 | Form 4 |
| 2026-05-09 | BRADLEY KEITH | Director | Shares withheld for taxes / exercise cost | 882 | $13.92 | $12.3K | Form 4 |
| 2026-05-07 | SCHADE CHRISTIAN S | Director | Grant / award / vesting (derivative) | 17,700 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Lo Renee Wonlai | Director | Grant / award / vesting (derivative) | 17,700 | $0.00 | $0 | Form 4 |
| 2026-05-07 | GRAVES JEFFREY A | Director | Grant / award / vesting (derivative) | 17,700 | $0.00 | $0 | Form 4 |
| 2026-05-07 | Clay Shaundra | Director | Grant / award / vesting (derivative) | 17,700 | $0.00 | $0 | Form 4 |
| 2026-05-07 | BRADLEY KEITH | Director | Grant / award / vesting (derivative) | 17,700 | $0.00 | $0 | Form 4 |
| 2026-05-07 | HILL BARBARA B | Director | Grant / award / vesting | 17,700 | $0.00 | $0 | Form 4 |
| 2026-05-07 | HILL BARBARA B | Director | Grant / award / vesting | 6,638 | $0.00 | $0 | Form 4 |
Ask the chat about IART's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: INTEGRA LIFESCIENCES HOLDINGS CORP (IART).
Last updated 2026-07-03 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.